Generation of therapeutic cells using extracellular components of target organs
US11760975B2 · kind B2 · utility
0Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2018 |
| Grant date | Sep 19, 2023 |
| Priority date | — |
| Expiry date | Oct 25, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2502/1358
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an ex vivo generated population of tissue-specific anti-inflammatory macrophages and methods of making and using such macrophages.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.